A Tyrosine Kinase Expression Signature Predicts the Post-Operative Clinical Outcome in Triple Negative Breast Cancers

Triple negative breast cancer (TNBC) represent 15% of breast cancers. Histoclinical features and marketed prognostic gene expression signatures (GES) failed to identify good- and poor-prognosis patients. Tyrosine kinases (TK) represent potential prognostic and/or therapeutic targets for TNBC. We sou...

Descripción completa

Detalles Bibliográficos
Autores principales: de Nonneville, Alexandre, Finetti, Pascal, Adelaide, José, Lambaudie, Éric, Viens, Patrice, Gonçalves, Anthony, Birnbaum, Daniel, Mamessier, Emilie, Bertucci, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721506/
https://www.ncbi.nlm.nih.gov/pubmed/31412533
http://dx.doi.org/10.3390/cancers11081158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721506/
https://www.ncbi.nlm.nih.gov/pubmed/31412533
http://dx.doi.org/10.3390/cancers11081158

Ejemplares similares